Please Wait.....
Report
South Korea Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 150 Pages I Mordor Intelligence
South Korea Diabetes Devices Market Analysis
The South Korea diabetes devices market is valued at USD 470.77 million in 2025 and is forecast to reach USD 545.77 million by 2030, reflecting a 3% CAGR as the market exits its rapid-expansion phase and enters steady, innovation-led growth. Demand remains resilient because 29.3% of adults aged 65 and older live with diabetes, a share that continues to rise as the population ages. Competitive intensity is sharpening as domestic manufacturers scale up, the National Health Insurance Service (NHIS) extends coverage for continuous glucose monitoring (CGM) and insulin pumps, and 5G-enabled telemedicine broadens access to specialist care. Simultaneously, strict reference pricing from the Health Insurance Review and Assessment Service (HIRA) is pressuring margins, compelling firms to localize production and recalibrate product portfolios. Market leadership is gravitating toward companies that pair hardware with artificial-intelligence software capable of predicting glycemic excursions, because outcomes-based reimbursement is gaining traction.
South Korea Diabetes Devices Market Trends and Insights
Rising Diabetes Prevalence and Earlier Age of Onset in South Korea
South Korea's diabetes prevalence has climbed to 15.5% among adults aged 30 and older, and 2.2% among adults aged 19-39, creating unprecedented lifetime demand for monitoring and delivery devices . Earlier onset means patients now spend more years using technology-enabled interventions, a pattern that lengthens device replacement cycles and raises cumulative revenue per patient. Roughly 87.1% of young adults with diabetes are obese, further increasing the need for continuous metabolic insight and prompting manufacturers to design low-profile, lifestyle-compatible CGM sensors. Awareness remains lower among young adults (43.3%) than seniors (78.8%), signaling untapped potential for targeted education and early screening programs that can lift device penetration. This demographic-driven demand is expected to keep the South Korea diabetes devices market on a stable upward trajectory even as price controls intensify.
Government Reimbursement Expansion for Advanced Glucose Monitoring and Insulin Delivery
NHIS began reimbursing CGM sensors and transmitters in 2019 and has since broadened eligibility for insulin pumps, reducing out-of-pocket costs and triggering a sharp rise in prescriptions across all age groups . Reimbursement now focuses on outcomes metrics such as time-in-range and hypoglycemia events, strengthening the business case for devices with proven clinical effectiveness. Earlier access to advanced tools is improving long-term glycemic control, which supports payer objectives to curb costly complications. The South Korea diabetes devices market is therefore seeing a pivot from single-function glucometers toward integrated monitoring-and-delivery ecosystems that align with payer priorities.
Stringent Pricing Controls and Reference Pricing Limiting Device Margins
HIRA benchmarks diabetes devices against reference countries, often granting reimbursement 30-40% below US and EU levels, squeezing returns on high-R&D products . CGM and pump makers confront a conundrum: South Korea's tech-forward market is ideal for showcasing innovation, yet margin realization lags. Firms respond by redesigning products with fewer bundled accessories, moving production to local plants, or adopting software-subscription models that shift revenue to post-sale services. Without structural change, low pricing will continually shadow the South Korea diabetes devices market.
Other drivers and restraints analyzed in the detailed report include:
Growth of Digital Health Ecosystem and 5G Connectivity Enabling Remote Diabetes Management / Increasing Adoption of Home-Based Self-Care Practices Among Aging Population / Domestic Med-Tech Manufacturing Investments Supported by K-Bio and Export Incentives / High Out-of-Pocket Costs for Advanced Insulin Pumps Despite Partial Reimbursement / Regulatory Delays for Novel Wearable and Implantable Sensors / Physician Preference for Established Therapies Slowing Uptake of Alternative Delivery Technologies /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Monitoring Devices account for 60.25% of 2025 revenue, underscoring their central role in real-time decision support across both Type 1 and insulin-treated Type 2 populations. Continuous glucose monitoring is the fastest-rising sub-segment as Korean Diabetes Association guidelines now recommend real-time CGM for all adults with Type 1 and for selected Type 2 cases. The South Korea diabetes devices market size for CGM is propelled by superior HbA1c reductions, with real-time users dropping from 8.9% to 7.1% versus intermittently-scanned users who fell from 8.6% to 7.5%. Local production by i-SENS lowers costs, potentially widening uptake.
Management Devices, while smaller today, are increasing at 4.2% CAGR and include patch pumps, traditional pumps, and connected pens that feed data to cloud dashboards. Domestic wearable-pump specialist EOFlow and multinationals Medtronic and Tandem are iterating closed-loop algorithms that adjust basal flow every five minutes, positioning the South Korea diabetes devices market for a coming wave of automated insulin delivery (AID) systems. Integration of CGM and pump data into unified apps is narrowing the functional gap between monitoring and management solutions, blurring category lines and encouraging ecosystem competition.
The Report Covers South Korean Diabetes Device Market Trends and is Segmented by Device Type (Monitoring Devices and Management Devices), by End User (Hospitals & Specialty Clinics, and Home-Care Settings), by Distribution Channel (Offline Pharmacies & DME Stores, and Online Channels). The Report Offers the Value (In USD) for the Above Segments.
List of Companies Covered in this Report:
Abbott Laboratories / Roche / i-Sens Inc. / Dexcom / Medtronic / Terumo Corp. / Ascensia / Arkray / Beckton Dickinson / Sanofi / Novo Nordisk / Eli Lilly and Company / Insulet / Ypsomed / Panasonic Healthcare (PHC Holdings) / Senseonics / B. Braun / Huons Co. Ltd. /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Diabetes Prevalence and Earlier Age of Onset in South Korea
4.2.2 Government Reimbursement Expansion for Advanced Glucose Monitoring and Insulin Delivery
4.2.3 Growth of Digital Health Ecosystem and 5G Connectivity Enabling Remote Diabetes Management
4.2.4 Government-led K-Bio strategy and tax incentives attracting local production of sensors, pumps, and smart pens
4.2.5 Increasing Adoption of Home-Based Self-Care Practices Among Aging Population
4.2.6 Domestic Med-Tech Manufacturing Investments Supported by K-Bio and Export Incentives
4.3 Market Restraints
4.3.1 Stringent Pricing Controls and Reference Pricing Limiting Device Margins
4.3.2 High Out-of-Pocket Costs for Advanced Insulin Pumps Despite Partial Reimbursement
4.3.3 Regulatory Delays for Novel Wearable and Implantable Sensors
4.3.4 Physician Preference for Established Therapies Slowing Uptake of Alternative Delivery Technologies (e.g., jet injectors)
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Outlook (KFDA, HIRA, NHIS)
4.6 Technological Outlook (AI-Enabled Dose-Decision Support, Integrated Tele-Diabetes)
4.7 Porter's Five Forces Analysis
4.7.1 Bargaining Power of Suppliers
4.7.2 Bargaining Power of Consumers
4.7.3 Threat of New Entrants
4.7.4 Threat of Substitute Products & Services
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value & Volume)
5.1 By Device Type
5.1.1 Monitoring Devices
5.1.1.1 Self-Monitoring Blood Glucose Devices
5.1.1.2 Continuous Glucose Monitoring Devices
5.1.2 Management Devices
5.1.2.1 Insulin Pumps
5.1.2.2 Insulin Syringes
5.1.2.3 Cartridges in Reusable Pens
5.1.2.4 Insulin Disposable Pens
5.1.2.5 Jet Injectors
5.2 By End User
5.2.1 Hospitals & Specialty Clinics
5.2.2 Home-Care Settings
5.3 By Distribution Channel
5.3.1 Offline Pharmacies & DME Stores
5.3.2 Online Channels
6 Market Indicators
6.1 Type-1 Diabetes Population
6.2 Type-2 Diabetes Population
7 Competitive Landscape
7.1 Market Concentration
7.2 Strategic Moves (M&A, Partnerships, Product Approvals)
7.3 Market Share Analysis
7.4 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
7.4.1 Abbott Diabetes Care
7.4.2 F. Hoffmann-La Roche Ltd.
7.4.3 i-Sens Inc.
7.4.4 Dexcom Inc.
7.4.5 Medtronic plc
7.4.6 Terumo Corp.
7.4.7 Ascensia Diabetes Care
7.4.8 ARKRAY Inc.
7.4.9 Becton, Dickinson and Company
7.4.10 Sanofi S.A.
7.4.11 Novo Nordisk A/S
7.4.12 Eli Lilly and Company
7.4.13 Insulet Corporation
7.4.14 Ypsomed AG
7.4.15 Panasonic Healthcare (PHC Holdings)
7.4.16 Senseonics Holdings Inc.
7.4.17 B. Braun Melsungen AG
7.4.18 Huons Co. Ltd.
8 Market Opportunities & Future Outlook
8.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security